News | Artificial Intelligence | January 15, 2019

Artificial Intelligence Used in Clinical Practice to Measure Breast Density

Algorithm achieves 94 percent agreement with radiologist interpretation

Artificial Intelligence Used in Clinical Practice to Measure Breast Density

January 15, 2019 — An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer, according to a new study published in the journal Radiology.1 The researchers said the study, the result of a collaboration between breast imagers and AI experts, represents a groundbreaking implementation of AI into routine clinical practice.

Breast density can mask cancers on mammography and is an independent risk factor for the disease. The masking effect and cancer risk are significant enough that many states have laws mandating women be notified if they have mammographically dense breasts. Despite its importance, breast density assessment is an imperfect science, and research has shown much discrepancy among radiologists in making density determinations.

“We’re dependent on human qualitative assessment of breast density, and that approach has significant flaws,” said study lead author Constance D. Lehman, M.D., Ph.D., from Massachusetts General Hospital (MGH) in Boston. “We need a more accurate tool.”

Lehman and colleagues collaborated with AI expert Regina Barzilay, Ph.D., professor of computer science and electrical engineering at the Massachusetts Institute of Technology in Cambridge, Mass., and her team to develop an algorithm that can automatically measure breast density. They used tens of thousands of high-quality digital mammograms from MGH to train and test the algorithm before implementing it in routine clinical practice. Eight radiologists then reviewed 10,763 mammograms that the model had determined were either dense or non-dense tissue.

The interpreting radiologist accepted the algorithm’s assessment in 10,149 of the mammograms, or 94 percent. Lehman noted that the 94 percent agreement rate between the radiologists and the algorithm does not necessarily mean the machine was wrong in 6 percent of the cases. Reader variability could affect the disagreement because radiologists visually assess breast density, which is subjective and qualitative.

“We were thrilled with the results,” Lehman said. “Now at Mass General, the deep learning algorithm processes all our screening mammograms and provides density, which is either accepted or rejected by the radiologists.”

“The study results show that the algorithm worked remarkably well,” Barzilay added. “But what’s more important is that it is being used every day to measure breast density in mammograms at a major hospital.”

The system has been in continuous operation at MGH since January and has processed approximately 16,000 images, according to Barzilay.

Lehman attributed the successful clinical implementation of the AI model to two components: the availability of high-quality, annotated data evaluated by expert radiologists, and the collaborative efforts of experienced, accomplished medical and computer science professionals.

“We have to have radiologists and other physicians who understand the pressing needs of our patients and can partner with computer scientists who are experts in AI,” she said. “That is the collaboration that is going to move the field forward.”

The algorithm has the potential to standardize and automate routine breast density assessment, the researchers said. On a broader scale, they see AI as central to the development of personalized breast cancer risk assessment for each woman who undergoes mammography. AI is uniquely suited to breast imaging because it can draw upon a large, mature database with advanced, structured reporting that links images with outcomes. This predictive power is a potential boon to all women, including groups who have been inadequately served by current prediction models. For instance, research has shown that current predictive models tend to underestimate risk in African-American women.

“We’re teaching the machine to directly predict cancer risk even before the radiologist will see any cancer,” Barzilay said. “The best time to control the disease is when it starts.”

“With AI, we now have the ability to leverage vast amounts of information into more personalized, more targeted care for our patients,” Lehman added. “In the case of breast cancer, we can better predict how likely a woman will have cancer in her future and improve the chances that it will be treated successfully.”

For more information: www.pubs.rsna.org/journal/radiology

 

Reference

1. Lehman C.D., Yala A., Schuster T., et al. Mammographic Breast Density Assessment Using Deep Learning: Clinical Implementation. Radiology, Oct. 16, 2018. https://doi.org/10.1148/radiol.2018180694

Related Content

Densitas Wins Major Procurement of Breast Density Software for DIMASOS Breast Screening Trial
News | Breast Density | September 20, 2019
Densitas Inc. announced it has won a procurement of its densitas densityai software for deployment in up to 24 breast...
Numerical simulation with a heterogeneous mouse

Numerical simulation with a heterogeneous mouse. (a) The geometry of the mouse with major organs near the source, and (b) the surface fluence computed with TIM-OS. Image courtesy of Rensselaer Polytechnic Institute.

News | Oncology Diagnostics | September 20, 2019
If researchers could observe drug delivery and its effect on cancer cells in real time, they would be able to tailor...
Screening Mammography Could Benefit Men at High Risk of Breast Cancer
News | Mammography | September 18, 2019
Selective mammography screening can provide potentially lifesaving early detection of breast cancer in men who are at...
Radiation After Immunotherapy Improves Progression-free Survival for Some Metastatic Lung Cancer Patients
News | Lung Cancer | September 18, 2019
Adding precisely aimed, escalated doses of radiation after patients no longer respond to immunotherapy reinvigorates...
The Artis icono biplane angiography system is designed for use in neurointerventions and interventional radiology

The Artis icono biplane angiography system is designed for use in neurointerventions and interventional radiology. Image courtesy of Siemens Healthineers.

Technology | Angiography | September 17, 2019
The U.S. Food and Drug Administration (FDA) has cleared the Artis icono, a high-precision family of angiography systems...
Noninvasive Radioablation Offers Long-term Benefits to High-risk Heart Arrhythmia Patients
News | Radiation Therapy | September 17, 2019
September 17, 2019 — Treating high-risk heart patients with a single, high dose of...
Varian Unveils Ethos Solution for Adaptive Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | September 16, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian...
Long-term Hormone Therapy Increases Mortality Risk for Low-PSA Men After Prostate Surgery
News | Prostate Cancer | September 16, 2019
Secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer...
3D Systems Earns Additional FDA Clearance for D2P Medical 3-D Printing Software

3D Systems’ D2P FDA-cleared software allows clinicians to 3-D-print diagnostic patient-specific anatomic models. Image courtesy of 3D Systems.

Technology | Medical 3-D Printing | September 12, 2019
3D Systems has received additional U.S. Food and Drug Administration (FDA) 510(k) clearance for its D2P software...
FDA Clears GE Healthcare's Critical Care Suite Chest X-ray AI
Technology | X-Ray | September 12, 2019
GE Healthcare announced the U.S. Food and Drug Administration’s (FDA) 510(k) clearance of Critical Care Suite, a...